New CEO at Polyplus-transfection
This article was originally published in Scrip
Polyplus-transfection (France), a privately held company developing solutions for molecular and cellular biology, today has appointed Mark Bloomfield CEO. He succeeds Frédéric Perraud, who continues as chief operating officer and deputy CEO. Mr Bloomfield has more than 15 years' senior sales, commercial leadership and business management experience with companies working in biotechnology tools and analytical instruments.